ClinicalTrials.gov
public full text
Public Domain
Preliminary Administration of EPO and Markers of Cardiac Ischemia Induced by CPB
The main objective is to observe the effects of erythropoietin administration on different blood markers of ischaemic cardiac lesions induced by cardiopulmonary bypass.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk Population#915248
- Erythropoietin and Platelet Activation Markers#1100405
- High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II Study#916440
- ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial#800940
- Feasibility and performance of a validated cerebral ultrasound scoring system for infants with hypoxic-ischemic encephalopathy. A retrospective study in a referral hospital in Ethiopia#928371
Record · ID 873584
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive